News from the Australian Cannabis Industry
Updated: Feb 10
The TGA (Therapeutic Goods Administration) confirmed it would start allowing the sale of low-dose cannabidiol (CBD) products over the counter by pharmacists as of december. Therefore all companies in the space are excited for what’s ahead and could receive a boost in the Australian medical cannabis market.
However the company FreshLeaf declares that the products might not be available until 2022, because they have to prove the quality standard of the products first.
While the companies prepare for the new policy there is still a lot of room to grow for the Australian cannabis market in the near future.
For more informations on hot topics join the Plutux Community and stay up to date!